Cargando…

CRISPR-based assay reveals SARS-CoV-2 RNA dynamic changes and redistribution patterns in non-human primate model

Mounting evidence indicates that SARS-CoV-2 can infect multiple systemic tissues, but few studies have evaluated SARS-CoV-2 RNA dynamics in multiple specimen types due to their reduced accessibility and diminished performance of RT-qPCR with non-respiratory specimens. Here, we employed an ultrasensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhen, Zhang, Lili, Lyon, Christopher J., Ning, Bo, Youngquist, Brady M., Niu, Alex, Beddingfield, Brandon J., Maness, Nicholas J., Saba, Nakhle S., Li, Chen-Zhong, Roy, Chad J., Hu, Tony Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Coronaviruses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865122/ https://www.ncbi.nlm.nih.gov/pubmed/35108153 http://dx.doi.org/10.1080/22221751.2022.2038020

Ejemplares similares

A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
por: An, Yaling, et al.
Publicado: (2022)

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
por: Tukhvatulin, Amir I., et al.
Publicado: (2022)

Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
por: Ning, Bo, et al.
Publicado: (2021)

Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations
por: Ning, Bo, et al.
Publicado: (2022)

RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant
por: Yang, Jianing, et al.
Publicado: (2022)

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector
por: Liang, Ziteng, et al.
Publicado: (2023)

Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation
por: Bei, Zhu-Chun, et al.
Publicado: (2023)

Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system
por: Chung, Hsing-Yi, et al.
Publicado: (2021)

Absence of SARS-CoV-2 in a captive white-tailed deer population in Alabama, USA
por: Barua, Subarna, et al.
Publicado: (2022)

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review
por: Gaudet, Lindsay A., et al.
Publicado: (2023)

SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron
por: Zhu, Yuanmei, et al.
Publicado: (2022)

Development of a CRISPR-Cas12a rapid diagnostic for human cytomegalovirus
por: Monk, Chandler H., et al.
Publicado: (2023)

Are parents’ willing to vaccinate their children against COVID-19? A qualitative study based on the Health Belief Model
por: Rajeh, Mona T., et al.
Publicado: (2023)

Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
por: Field, C. J., et al.
Publicado: (2022)

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants
por: Yan, Qihong, et al.
Publicado: (2022)

CRISPR-based assays for low-resource settings
por: Huang, Zhen, et al.
Publicado: (2023)

Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
por: Das, Rituparna, et al.
Publicado: (2023)

Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment”
por: Das, Rituparna, et al.
Publicado: (2023)

Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein
por: Jiang, Sheng, et al.
Publicado: (2022)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023)

Possible recombination between two variants of concern in a COVID-19 patient
por: He, Yaqing, et al.
Publicado: (2022)

Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell–cell fusion, and neutralization sensitivity
por: Zhang, Li, et al.
Publicado: (2022)

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
por: Liang, Huang, et al.
Publicado: (2022)

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
por: Bills, Cody J., et al.
Publicado: (2023)

Correlates of uptake of COVID-19 vaccines and motivation to vaccinate among Malawian adults
por: Whitehead, Hannah S., et al.
Publicado: (2023)

The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infection
por: Fears, Alyssa C., et al.
Publicado: (2022)

Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally infected, captive white-tailed deer (Odocoileus virginianus), Texas
por: Hamer, Sarah A., et al.
Publicado: (2022)

SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines
por: Hickey, Thomas E., et al.
Publicado: (2023)

A comparative analysis exposes an amplification delay distinctive to SARS-CoV-2 Omicron variants of clinical and public health relevance
por: Brown, K.L., et al.
Publicado: (2022)

Animal alphacoronaviruses found in human patients with acute respiratory illness in different countries.
por: Vlasova, Anastasia N., et al.
Publicado: (2022)

Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated
por: d’Almeida, Sascha, et al.
Publicado: (2023)

COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study
por: Chery, Maurice J., et al.
Publicado: (2023)

Identification of a recombinant equine coronavirus in donkey, China
por: Qi, Peng-Fei, et al.
Publicado: (2022)

SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species
por: Moustaqil, Mehdi, et al.
Publicado: (2021)

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
por: Pérez-Vargas, Jimena, et al.
Publicado: (2023)

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
por: Ai, Jingwen, et al.
Publicado: (2022)

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
por: Xia, Hongjie, et al.
Publicado: (2023)

Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing
por: Tong, Renyang, et al.
Publicado: (2023)

Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial
por: Sánchez Barrueco, Álvaro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b3ddmpplfecsrjjvdqtgud6b7c